US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Onconetix Inc.

0.6970

+0.03345.03%

Post-market: 0.6923-0.0047-0.67%16:04 EST

Volume:77.77K

Turnover:51.00K

Market Cap:1.09M

PE:-0.02

High:0.6970

Open:0.6643

Low:0.6241

Close:0.6636

52wk High:32.30

52wk Low:0.6200

Shares:1.56M

Float Shares:1.24M

Volume Ratio:0.36

T/O Rate:6.26%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-32.5790

EPS(LYR):-1,823.3933

ROE:-221.37%

ROA:-7.41%

PB:0.32

PE(LYR):0.00

Loading ...

Overview Company News Filings

Oncopeptides Doubles 2025 Sales and Raises Capital to Drive Glioblastoma Push

BRIEF-Realbotix Corp. Announces The Sale Of Realbotix, Llc Subsidiary To A Nasdaq Listed Issuer

BRIEF-Onconetix To Acquire Realbotix Llc, Usa-Based, Ai-Powered Humanoid Robotics Company

Onconetix Acquires Realbotix in All-Stock Deal

Onconetix to Acquire Realbotix Llc, USA-Based, AI-Powered Humanoid Robotics Company

THOMSON REUTERS

Onconetix Inc - Andrew Kiguel Will Become CEO of Combined Company Following Closing

THOMSON REUTERS

Onconetix Inc - Andrew Kiguel to Become CEO of Combined Company

THOMSON REUTERS

Onconetix Inc - Will Acquire 100% of Issued and Outstanding Equity Interests of Realbotix in an All-Stock Transaction

THOMSON REUTERS

Onconetix Inc: Realbotix Parent Will Own Between 75% and 90% of Fully Diluted Common Shares of Combined Company

THOMSON REUTERS

Realbotix Corp - Onconetix to Buy 100% of Realbotix, Llc in All-Stock Deal

THOMSON REUTERS

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM

Onconetix Inc. Held Special Shareholder Meeting

Oncopeptides Lifts 2025 Sales but Delays Cash-Flow Break-Even to 2027

Onconetix Inc: Files Prospectus for Resale of 29.8 Mln Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS

Onconetix Inc. Files Initial Statement of Beneficial Ownership for Director Sarah Romano

Onconetix Inc. Held Annual Shareholder Meeting

Proteomedix AG Launches PRIME Study Under Onconetix Inc

Onconetix Inc - Files Prospectus For Resale Of 22.1 Million Shares Of Common Stock By Selling Stockholders - SEC Filing

BRIEF-Onconetix Inc - Files Prospectus For Resale Of 22.1 Million Shares Of Common Stock By Selling Stockholders - SEC Filing

Onconetix Inc. Announces Date for Upcoming Annual Stockholders Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ONCO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ONCO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONCO\",,,,,undefined,":{"symbol":"ONCO","market":"US","secType":"STK","nameCN":"Onconetix Inc.","latestPrice":0.697,"timestamp":1771966800000,"preClose":0.6636,"halted":0,"volume":77774,"hourTrading":{"tag":"盘后","latestPrice":0.6923,"preClose":0.697,"latestTime":"16:04 EST","volume":30,"amount":20.7784008,"timestamp":1771967083690,"change":-0.0047,"changeRate":-0.006743,"amplitude":0},"delay":0,"changeRate":0.0503315250150693,"floatShares":1243200,"shares":1560668,"eps":-32.579,"marketStatus":"Post-Mkt","change":0.0334,"latestTime":"02-24 16:14:00 EST","open":0.6643,"high":0.697,"low":0.624101,"amount":50998.898111,"amplitude":0.109854,"askPrice":0.6923,"askSize":35,"bidPrice":0.64,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-32.579,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771981200000},"marketStatusCode":4,"adr":0,"listingDate":1645160400000,"exchange":"NASDAQ","adjPreClose":0.6636,"preHourTrading":{"tag":"盘前","latestPrice":0.6643,"preClose":0.6636,"latestTime":"08:07 EST","volume":843,"amount":580.53849168,"timestamp":1771938440008,"change":0.0007,"changeRate":0.001055,"amplitude":0.149638},"postHourTrading":{"tag":"盘后","latestPrice":0.6923,"preClose":0.697,"latestTime":"16:04 EST","volume":30,"amount":20.7784008,"timestamp":1771967083690,"change":-0.0047,"changeRate":-0.006743,"amplitude":0},"volumeRatio":0.361935},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONCO\",,,,,undefined,":{"symbol":"ONCO","floatShares":1243200,"roa":"-7.41%","roe":"-221.37%","lyrEps":-1823.3933,"volumeRatio":0.361935,"shares":1560668,"dividePrice":0,"high":0.697,"amplitude":0.109854,"preClose":0.6636,"low":0.624101,"week52Low":0.620001,"pbRate":"0.32","psRate":"0.89","week52High":32.3,"institutionHeld":0,"latestPrice":0.697,"committee":0.481481,"eps":-32.579,"divideRate":0,"volume":77774,"delay":0,"ttmEps":-32.579,"open":0.6643,"prevYearClose":1.56,"prevWeekClose":0.758,"prevMonthClose":1.42,"prevQuarterClose":1.56,"fiveDayClose":0.7848,"twentyDayClose":1.45,"sixtyDayClose":2.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONCO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"ONCO","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-6.25},{"market":"US","date":"2025-08-14","symbol":"ONCO","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-4.05},{"market":"US","date":"2025-06-13","symbol":"ONCO","defaultRemindTime":1749821400000,"type":"split","dateTimestamp":1749787200000,"forFactor":85,"toFactor":1,"ratio":85},{"market":"US","date":"2025-06-12","symbol":"ONCO","fiscalQuarterEnding":"2025/03","expectedEps":0,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1749700800000,"reportTimeType":"post","actualEps":0.25},{"market":"US","date":"2024-09-24","symbol":"ONCO","defaultRemindTime":1727184600000,"type":"split","dateTimestamp":1727150400000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONCO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONCO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONCO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONCO","date":"2026-02-23","current":-0.019948,"percent":0.9,"low":-0.968106,"twenty":-0.168102,"median":-0.081622,"eighty":-0.043242,"high":-0.008728,"avg":-0.124482,"sd":0.158678,"marketCap":1178701},"quantilePoints":[{"date":"2023-12-29","current":-0.201955,"twenty":-0.205826,"median":-0.201955,"eighty":-0.193917,"marketCap":3691085},{"date":"2024-01-05","current":-0.194459,"twenty":-0.201955,"median":-0.195264,"eighty":-0.193719,"marketCap":3554077},{"date":"2024-01-12","current":-0.190736,"twenty":-0.197125,"median":-0.193719,"eighty":-0.190736,"marketCap":3486030},{"date":"2024-01-19","current":-0.173836,"twenty":-0.19628,"median":-0.192899,"eighty":-0.180094,"marketCap":3177158},{"date":"2024-01-26","current":-0.342039,"twenty":-0.19628,"median":-0.189647,"eighty":-0.1728,"marketCap":6251352},{"date":"2024-02-02","current":-0.174037,"twenty":-0.202407,"median":-0.192246,"eighty":-0.173635,"marketCap":3180835},{"date":"2024-02-09","current":-0.164782,"twenty":-0.198091,"median":-0.186679,"eighty":-0.170436,"marketCap":3011681},{"date":"2024-02-16","current":-0.205696,"twenty":-0.198091,"median":-0.184801,"eighty":-0.168042,"marketCap":3759458},{"date":"2024-02-23","current":-0.206429,"twenty":-0.205989,"median":-0.188558,"eighty":-0.169852,"marketCap":3772853},{"date":"2024-03-01","current":-0.208872,"twenty":-0.20842,"median":-0.192572,"eighty":-0.172015,"marketCap":3817502},{"date":"2024-03-08","current":-0.22182,"twenty":-0.213025,"median":-0.193719,"eighty":-0.17277,"marketCap":4054143},{"date":"2024-03-15","current":-0.201665,"twenty":-0.217422,"median":-0.196597,"eighty":-0.172951,"marketCap":3685787},{"date":"2024-03-22","current":-0.203986,"twenty":-0.21515,"median":-0.197125,"eighty":-0.173514,"marketCap":3728204},{"date":"2024-03-28","current":-0.2002,"twenty":-0.212952,"median":-0.198734,"eighty":-0.173916,"marketCap":3658998},{"date":"2024-04-05","current":-0.204475,"twenty":-0.211193,"median":-0.198734,"eighty":-0.174238,"marketCap":3737134},{"date":"2024-04-12","current":-0.093154,"twenty":-0.209947,"median":-0.197125,"eighty":-0.174238,"marketCap":3484866},{"date":"2024-04-19","current":-0.079022,"twenty":-0.209385,"median":-0.195935,"eighty":-0.172739,"marketCap":2956187},{"date":"2024-04-26","current":-0.07186,"twenty":-0.2087,"median":-0.194214,"eighty":-0.166713,"marketCap":2688255},{"date":"2024-05-03","current":-0.067443,"twenty":-0.208428,"median":-0.193586,"eighty":-0.15949,"marketCap":2523030},{"date":"2024-05-10","current":-0.066787,"twenty":-0.208202,"median":-0.192246,"eighty":-0.083892,"marketCap":2498469},{"date":"2024-05-17","current":-0.084155,"twenty":-0.207504,"median":-0.190061,"eighty":-0.075083,"marketCap":3148205},{"date":"2024-05-24","current":-0.069112,"twenty":-0.206722,"median":-0.188558,"eighty":-0.074211,"marketCap":3157136},{"date":"2024-05-31","current":-0.116278,"twenty":-0.206282,"median":-0.18621,"eighty":-0.07464,"marketCap":5311760},{"date":"2024-06-07","current":-0.08705,"twenty":-0.205452,"median":-0.178162,"eighty":-0.074985,"marketCap":3976563},{"date":"2024-06-14","current":-0.070578,"twenty":-0.204475,"median":-0.174289,"eighty":-0.074605,"marketCap":3224120},{"date":"2024-06-21","current":-0.075759,"twenty":-0.204269,"median":-0.173433,"eighty":-0.074474,"marketCap":3460793},{"date":"2024-06-28","current":-0.100148,"twenty":-0.204171,"median":-0.17293,"eighty":-0.07408,"marketCap":4574945},{"date":"2024-07-05","current":-0.078056,"twenty":-0.203986,"median":-0.171849,"eighty":-0.074605,"marketCap":3565733},{"date":"2024-07-12","current":-0.070578,"twenty":-0.203986,"median":-0.1678,"eighty":-0.07371,"marketCap":3224120},{"date":"2024-07-15","current":-0.074977,"twenty":-0.203742,"median":-0.166895,"eighty":-0.073758,"marketCap":3425069},{"date":"2024-08-02","current":-0.097024,"twenty":-0.203498,"median":-0.165989,"eighty":-0.073806,"marketCap":4432207},{"date":"2024-08-09","current":-0.087113,"twenty":-0.202765,"median":-0.164732,"eighty":-0.074211,"marketCap":3979455},{"date":"2024-08-16","current":-0.091286,"twenty":-0.202441,"median":-0.148887,"eighty":-0.074675,"marketCap":4170088},{"date":"2024-08-23","current":-0.103936,"twenty":-0.201937,"median":-0.114182,"eighty":-0.074801,"marketCap":4747943},{"date":"2024-08-30","current":-0.075134,"twenty":-0.201812,"median":-0.103936,"eighty":-0.074889,"marketCap":3991369},{"date":"2024-09-06","current":-0.071275,"twenty":-0.201372,"median":-0.101719,"eighty":-0.07464,"marketCap":3786324},{"date":"2024-09-13","current":-0.074303,"twenty":-0.199931,"median":-0.100613,"eighty":-0.073472,"marketCap":3947190},{"date":"2024-09-20","current":-0.06477,"twenty":-0.198832,"median":-0.097806,"eighty":-0.072904,"marketCap":3440758},{"date":"2024-09-27","current":-0.047041,"twenty":-0.198734,"median":-0.097089,"eighty":-0.072123,"marketCap":2498940},{"date":"2024-10-04","current":-0.702586,"twenty":-0.201861,"median":-0.097806,"eighty":-0.072322,"marketCap":37323522},{"date":"2024-10-11","current":-0.804153,"twenty":-0.203742,"median":-0.100613,"eighty":-0.072761,"marketCap":42719049},{"date":"2024-10-18","current":-0.880664,"twenty":-0.205452,"median":-0.101719,"eighty":-0.072874,"marketCap":46783580},{"date":"2024-10-25","current":-0.626146,"twenty":-0.208304,"median":-0.106675,"eighty":-0.072904,"marketCap":33262793},{"date":"2024-10-31","current":-0.46218,"twenty":-0.209727,"median":-0.114182,"eighty":-0.073022,"marketCap":24552412},{"date":"2024-11-08","current":-0.379425,"twenty":-0.217422,"median":-0.148887,"eighty":-0.073022,"marketCap":20156203},{"date":"2024-11-15","current":-0.254511,"twenty":-0.219865,"median":-0.164732,"eighty":-0.073315,"marketCap":13520416},{"date":"2024-11-22","current":-0.17644,"twenty":-0.219499,"median":-0.165989,"eighty":-0.073412,"marketCap":9373049},{"date":"2024-11-29","current":-0.107738,"twenty":-0.218815,"median":-0.165889,"eighty":-0.07365,"marketCap":5723366},{"date":"2024-12-06","current":-0.098369,"twenty":-0.217666,"median":-0.160355,"eighty":-0.073901,"marketCap":5225682},{"date":"2024-12-13","current":-0.075065,"twenty":-0.217422,"median":-0.144138,"eighty":-0.074232,"marketCap":3873640},{"date":"2024-12-20","current":-0.057866,"twenty":-0.214393,"median":-0.114182,"eighty":-0.073393,"marketCap":2986104},{"date":"2024-12-27","current":-0.056259,"twenty":-0.21261,"median":-0.110145,"eighty":-0.072963,"marketCap":2903156},{"date":"2025-01-03","current":-0.104658,"twenty":-0.211193,"median":-0.107738,"eighty":-0.072874,"marketCap":5400701},{"date":"2025-01-10","current":-0.087844,"twenty":-0.210021,"median":-0.107738,"eighty":-0.072904,"marketCap":4533072},{"date":"2025-01-17","current":-0.082411,"twenty":-0.209556,"median":-0.104481,"eighty":-0.073022,"marketCap":4252710},{"date":"2025-01-24","current":-0.077155,"twenty":-0.208872,"median":-0.103034,"eighty":-0.073022,"marketCap":3981472},{"date":"2025-01-31","current":-0.090802,"twenty":-0.208442,"median":-0.10198,"eighty":-0.073315,"marketCap":4685695},{"date":"2025-02-07","current":-0.105075,"twenty":-0.208406,"median":-0.10224,"eighty":-0.073412,"marketCap":5422267},{"date":"2025-02-14","current":-0.087185,"twenty":-0.207895,"median":-0.101296,"eighty":-0.07371,"marketCap":4499063},{"date":"2025-02-21","current":-0.067511,"twenty":-0.207113,"median":-0.100929,"eighty":-0.073393,"marketCap":3483788},{"date":"2025-02-28","current":-0.049315,"twenty":-0.206527,"median":-0.100148,"eighty":-0.072875,"marketCap":2544824},{"date":"2025-03-07","current":-0.036777,"twenty":-0.205843,"median":-0.098528,"eighty":-0.072195,"marketCap":1897835},{"date":"2025-03-14","current":-0.020864,"twenty":-0.204719,"median":-0.098369,"eighty":-0.071225,"marketCap":1076656},{"date":"2025-03-21","current":-0.020944,"twenty":-0.204269,"median":-0.097978,"eighty":-0.070572,"marketCap":1080803},{"date":"2025-03-28","current":-0.017312,"twenty":-0.204032,"median":-0.097741,"eighty":-0.069818,"marketCap":893342},{"date":"2025-04-04","current":-0.0122,"twenty":-0.203986,"median":-0.097063,"eighty":-0.069089,"marketCap":629570},{"date":"2025-04-11","current":-0.009323,"twenty":-0.203009,"median":-0.096444,"eighty":-0.068134,"marketCap":481094},{"date":"2025-04-17","current":-0.00958,"twenty":-0.202765,"median":-0.095559,"eighty":-0.067511,"marketCap":494366},{"date":"2025-04-25","current":-0.011091,"twenty":-0.202279,"median":-0.093131,"eighty":-0.066512,"marketCap":572336},{"date":"2025-05-02","current":-0.012554,"twenty":-0.201928,"median":-0.092586,"eighty":-0.065058,"marketCap":647818},{"date":"2025-05-09","current":-0.011702,"twenty":-0.201763,"median":-0.090913,"eighty":-0.063884,"marketCap":603856},{"date":"2025-05-16","current":-0.011991,"twenty":-0.200786,"median":-0.088907,"eighty":-0.05784,"marketCap":618787},{"date":"2025-05-23","current":-0.023761,"twenty":-0.199394,"median":-0.088096,"eighty":-0.054651,"marketCap":1226160},{"date":"2025-05-30","current":-0.068768,"twenty":-0.198807,"median":-0.087659,"eighty":-0.054651,"marketCap":3548673},{"date":"2025-06-06","current":-0.052528,"twenty":-0.198734,"median":-0.087113,"eighty":-0.054651,"marketCap":3082910},{"date":"2025-06-13","current":-0.058572,"twenty":-0.19856,"median":-0.086807,"eighty":-0.054651,"marketCap":3286955},{"date":"2025-06-20","current":-0.037197,"twenty":-0.198065,"median":-0.086363,"eighty":-0.052105,"marketCap":2087452},{"date":"2025-06-27","current":-0.043242,"twenty":-0.196958,"median":-0.084244,"eighty":-0.047082,"marketCap":2426662},{"date":"2025-07-03","current":-0.043242,"twenty":-0.196291,"median":-0.084155,"eighty":-0.044358,"marketCap":2426662},{"date":"2025-07-11","current":-0.040638,"twenty":-0.196069,"median":-0.082194,"eighty":-0.043707,"marketCap":2280541},{"date":"2025-07-18","current":-0.033199,"twenty":-0.195802,"median":-0.081722,"eighty":-0.043242,"marketCap":1863050},{"date":"2025-07-25","current":-0.033571,"twenty":-0.194459,"median":-0.079938,"eighty":-0.040587,"marketCap":1883925},{"date":"2025-08-01","current":-0.033106,"twenty":-0.194214,"median":-0.079059,"eighty":-0.039615,"marketCap":1857832},{"date":"2025-08-08","current":-0.024829,"twenty":-0.194214,"median":-0.078385,"eighty":-0.038313,"marketCap":1393374},{"date":"2025-08-15","current":-0.08511,"twenty":-0.193719,"median":-0.078056,"eighty":-0.037197,"marketCap":4776225},{"date":"2025-08-22","current":-0.098303,"twenty":-0.193453,"median":-0.078868,"eighty":-0.037476,"marketCap":4343428},{"date":"2025-08-29","current":-0.10495,"twenty":-0.192899,"median":-0.079376,"eighty":-0.038127,"marketCap":4637112},{"date":"2025-09-05","current":-0.100402,"twenty":-0.192377,"median":-0.080109,"eighty":-0.038276,"marketCap":4436170},{"date":"2025-09-12","current":-0.109498,"twenty":-0.191038,"median":-0.081809,"eighty":-0.038536,"marketCap":4838053},{"date":"2025-09-19","current":-0.10495,"twenty":-0.190587,"median":-0.082411,"eighty":-0.03889,"marketCap":4637112},{"date":"2025-09-26","current":-0.111597,"twenty":-0.189768,"median":-0.084184,"eighty":-0.039262,"marketCap":4930795},{"date":"2025-10-03","current":-0.110197,"twenty":-0.189377,"median":-0.08511,"eighty":-0.039559,"marketCap":4868967},{"date":"2025-10-10","current":-0.144131,"twenty":-0.188712,"median":-0.086363,"eighty":-0.039737,"marketCap":6368300},{"date":"2025-10-17","current":-0.12174,"twenty":-0.188197,"median":-0.086815,"eighty":-0.039794,"marketCap":5378958},{"date":"2025-10-24","current":-0.117582,"twenty":-0.186589,"median":-0.087149,"eighty":-0.040024,"marketCap":5195267},{"date":"2025-10-31","current":-0.132966,"twenty":-0.185889,"median":-0.087844,"eighty":-0.040486,"marketCap":5875000},{"date":"2025-11-07","current":-0.093673,"twenty":-0.185003,"median":-0.088278,"eighty":-0.040628,"marketCap":4138852},{"date":"2025-11-14","current":-0.085873,"twenty":-0.182146,"median":-0.088907,"eighty":-0.041415,"marketCap":3794224},{"date":"2025-11-21","current":-0.073999,"twenty":-0.178698,"median":-0.088096,"eighty":-0.042023,"marketCap":3636356},{"date":"2025-11-28","current":-0.088291,"twenty":-0.177065,"median":-0.087968,"eighty":-0.042796,"marketCap":4338657},{"date":"2025-12-05","current":-0.09369,"twenty":-0.175481,"median":-0.088091,"eighty":-0.043242,"marketCap":4603970},{"date":"2025-12-12","current":-0.073364,"twenty":-0.174661,"median":-0.088061,"eighty":-0.043242,"marketCap":3605143},{"date":"2025-12-19","current":-0.058437,"twenty":-0.174238,"median":-0.087474,"eighty":-0.043521,"marketCap":2871629},{"date":"2025-12-26","current":-0.048274,"twenty":-0.173957,"median":-0.087113,"eighty":-0.043819,"marketCap":2372215},{"date":"2026-01-02","current":-0.049365,"twenty":-0.173675,"median":-0.086815,"eighty":-0.04406,"marketCap":2425823},{"date":"2026-01-09","current":-0.054428,"twenty":-0.172991,"median":-0.086363,"eighty":-0.044414,"marketCap":2674625},{"date":"2026-01-16","current":-0.050947,"twenty":-0.1728,"median":-0.085192,"eighty":-0.044693,"marketCap":2503574},{"date":"2026-01-23","current":-0.05158,"twenty":-0.172679,"median":-0.084244,"eighty":-0.044916,"marketCap":2534674},{"date":"2026-01-30","current":-0.04715,"twenty":-0.171019,"median":-0.084,"eighty":-0.044916,"marketCap":2316972},{"date":"2026-02-06","current":-0.038606,"twenty":-0.170195,"median":-0.082411,"eighty":-0.044637,"marketCap":1897118},{"date":"2026-02-13","current":-0.033543,"twenty":-0.168633,"median":-0.081838,"eighty":-0.044358,"marketCap":1648315},{"date":"2026-02-20","current":-0.022784,"twenty":-0.168208,"median":-0.081672,"eighty":-0.043242,"marketCap":1119610},{"date":"2026-02-23","current":-0.023986,"twenty":-0.168102,"median":-0.081622,"eighty":-0.043242,"marketCap":1178701}],"updateTime":1771950976939},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONCO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612700684","title":"Oncopeptides Doubles 2025 Sales and Raises Capital to Drive Glioblastoma Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2612700684","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612700684?lang=en_us&edition=fundamental","pubTime":"2026-02-19 15:34","pubTimestamp":1771486441,"startTime":"0","endTime":"0","summary":"The latest update is out from Oncopeptides AB ( ($SE:ONCO) ). Oncopeptides reported strong commercial momentum in 2025, with full-year net sales ri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncopeptides-doubles-2025-sales-and-raises-capital-to-drive-glioblastoma-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncopeptides-doubles-2025-sales-and-raises-capital-to-drive-glioblastoma-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0589944569.HKD","SG9999001135.SGD","SG9999005177.SGD","SG9999013460.SGD","LU0532188223.SGD","LU2065169927.USD","IE0034224299.USD","SG9999004360.SGD","LU1770036033.HKD","BK4554","LU0264606111.USD","LU0251143029.SGD","ONCO","LU0737861269.HKD","LU2065171311.SGD","LU2543165471.USD","LU0048573645.USD","LU0979878070.USD","LU0175139822.USD","LU1242518857.USD","SG9999002620.SGD","LU0261945553.USD","SG9999002414.USD","SG9999002679.SGD","LU0441851309.USD","LU0345775950.USD","LU0345776255.USD","BK4588","LU0072462343.USD","BK4085","SGXZ58947870.SGD","SG9999013478.USD","IE00BD6J9T35.USD","LU0823039010.USD","LU0516422952.EUR","LU2360107671.USD","LU0499858602.USD","LU2065170008.USD","LU0348788117.USD","BK4503","LU2045819591.USD","BK4548","BK4551","LU0499858438.USD","LU0516423091.SGD","LU2008162690.USD","LU0572939691.SGD","SG9999014492.USD","LU1048588211.SGD","LU2065171402.SGD","SG9999006266.SGD","LU2238330802.EUR","LU0516422440.USD","LU2152927971.USD","SG9999002604.SGD","LU0289960550.SGD","BK4535","LU0516423174.USD","LU1839390173.USD","BK4566","LU2125910500.SGD","LU0516422366.SGD","SG9999013486.USD","LU0823038988.USD","IE0001KFT4U8.USD","IE0031814969.USD","BK4581","LU2177674079.SGD","LU1861217088.USD","LU1861220207.SGD","LU0210637038.USD","LU1242518931.SGD","BK4585","LU2125910849.SGD","LU0572940350.SGD","SG9999014484.SGD","SG9999002406.SGD","BK4220"],"gpt_icon":0},{"id":"2610927917","title":"BRIEF-Realbotix Corp. Announces The Sale Of Realbotix, Llc Subsidiary To A Nasdaq Listed Issuer","url":"https://stock-news.laohu8.com/highlight/detail?id=2610927917","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610927917?lang=en_us&edition=fundamental","pubTime":"2026-02-12 22:40","pubTimestamp":1770907244,"startTime":"0","endTime":"0","summary":"BRIEF-Realbotix Corp. Announces The Sale Of Realbotix, Llc Subsidiary To A Nasdaq Listed IssuerFeb 12 (Reuters) - Realbotix Corp XBOT.V:REALBOTIX CORP. ANNOUNCES THE SALE OF REALBOTIX, LLC SUBSIDIARY ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nTUA9WJD18:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2610211859","title":"BRIEF-Onconetix To Acquire Realbotix Llc, Usa-Based, Ai-Powered Humanoid Robotics Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2610211859","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610211859?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:31","pubTimestamp":1770903088,"startTime":"0","endTime":"0","summary":"BRIEF-Onconetix To Acquire Realbotix Llc, Usa-Based, Ai-Powered Humanoid Robotics CompanyFeb 12 (Reuters) - Onconetix Inc ONCO.O:ONCONETIX TO ACQUIRE REALBOTIX LLC, USA-BASED, AI-POWERED HUMANOID ROBO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nTUA8XYYSN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2610929370","title":"Onconetix Acquires Realbotix in All-Stock Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2610929370","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610929370?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:01","pubTimestamp":1770901267,"startTime":"0","endTime":"0","summary":"Onconetix Inc. will acquire all issued and outstanding equity interests of Realbotix LLC in exchange for newly issued shares of Onconetix common stock. Following the completion of the transaction, expected in the second half of 2026, Realbotix Parent will own between 75% and 90% of the fully diluted shares of the combined company, depending on Onconetix’s cash position at closing. Andrew Kiguel, current CEO of Realbotix Corp, will become CEO of the combined company. Realbotix, recognized for its AI-powered humanoid robotics and enterprise partnerships with companies like Ericsson, will bring its portfolio and technological advancements to the newly combined entity, which is anticipated to trade on Nasdaq. The boards of both companies have unanimously approved the transaction, which remains subject to customary closing conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely inf","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL7nGlYC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014039.USD","BK4112","IE00BGHQF748.EUR","ONCO","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014021.USD","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4585","LU2095319765.USD","BK4588","BK4139","NDAQ"],"gpt_icon":0},{"id":"2610929804","title":"Onconetix to Acquire Realbotix Llc, USA-Based, AI-Powered Humanoid Robotics Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2610929804","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610929804?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:00","pubTimestamp":1770901209,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nFWN3Z80OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2610929590","title":"Onconetix Inc - Andrew Kiguel Will Become CEO of Combined Company Following Closing","url":"https://stock-news.laohu8.com/highlight/detail?id=2610929590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610929590?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:00","pubTimestamp":1770901209,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nFWN3Z80OT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2610992951","title":"Onconetix Inc - Andrew  Kiguel to Become CEO of Combined Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2610992951","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610992951?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:00","pubTimestamp":1770901206,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nTUA8XYYSN:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2610929890","title":"Onconetix Inc - Will Acquire 100% of Issued and Outstanding Equity Interests of Realbotix in an All-Stock Transaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2610929890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610929890?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:00","pubTimestamp":1770901206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nTUA8XYYSN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2610929359","title":"Onconetix Inc: Realbotix Parent Will Own Between 75% and 90% of Fully Diluted Common Shares of Combined Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2610929359","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610929359?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:00","pubTimestamp":1770901206,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nTUA8XYYSN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2610929592","title":"Realbotix Corp - Onconetix to Buy 100% of Realbotix, Llc in All-Stock Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2610929592","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610929592?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:00","pubTimestamp":1770901201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nTUA9WJD18:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2610192617","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:55 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2610192617","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610192617?lang=en_us&edition=fundamental","pubTime":"2026-02-12 20:55","pubTimestamp":1770900900,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:55 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nAQN2LLZ18:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2610595661","title":"Onconetix Inc. Held Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2610595661","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610595661?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:01","pubTimestamp":1770674469,"startTime":"0","endTime":"0","summary":"On February 3, 2026, Onconetix Inc. held a special meeting of stockholders. Stockholders approved an amendment to the company’s Amended and Restated Certificate of Incorporation authorizing a reverse stock split of common stock at a ratio ranging from 1-for-2 to 1-for-50, with the specific ratio to be determined by the Board of Directors. Stockholders also approved the proposal to adjourn the meeting if necessary to solicit additional proxies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 09, 2026, and is solely resp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL1nLXjM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2603980159","title":"Oncopeptides Lifts 2025 Sales but Delays Cash-Flow Break-Even to 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2603980159","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603980159?lang=en_us&edition=fundamental","pubTime":"2026-01-16 02:33","pubTimestamp":1768502002,"startTime":"0","endTime":"0","summary":"Oncopeptides AB ( ($SE:ONCO) ) has shared an announcement. Oncopeptides reported that unaudited net sales reached 18.6 million SEK in the fourth qu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncopeptides-lifts-2025-sales-but-delays-cash-flow-break-even-to-2027?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncopeptides-lifts-2025-sales-but-delays-cash-flow-break-even-to-2027?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2177674079.SGD","LU2065170008.USD","LU0348788117.USD","LU2008162690.USD","LU1048588211.SGD","LU0289960550.SGD","SG9999005177.SGD","BK4535","LU0499858602.USD","LU0979878070.USD","LU2543165471.USD","LU0175139822.USD","LU2360107671.USD","LU0210637038.USD","LU0572940350.SGD","LU0516423174.USD","LU2065171402.SGD","LU0516422440.USD","SGXZ58947870.SGD","LU1839390173.USD","ONCO","LU0516422952.EUR","BK4503","BK4220","BK4588","LU0264606111.USD","LU1770036033.HKD","LU1242518931.SGD","LU0823038988.USD","LU0048573645.USD","LU0737861269.HKD","SG9999002604.SGD","LU0516423091.SGD","BK4085","SG9999014492.USD","LU0261945553.USD","BK4566","LU0499858438.USD","LU1861220207.SGD","LU2045819591.USD","LU0251143029.SGD","LU2065169927.USD","LU2152927971.USD","LU2065171311.SGD","BK4548","IE0034224299.USD","SG9999002414.USD","SG9999013478.USD","SG9999002406.SGD","IE0001KFT4U8.USD","SG9999014484.SGD","BK4585","LU0572939691.SGD","SG9999002620.SGD","IE00BD6J9T35.USD","SG9999013486.USD","LU2125910500.SGD","LU1861217088.USD","BK4554","LU0345775950.USD","LU0589944569.HKD","SG9999006266.SGD","LU2238330802.EUR","BK4581","LU0441851309.USD","BK4551","LU0823039010.USD","SG9999001135.SGD","SG9999002679.SGD","LU1242518857.USD","LU0072462343.USD","LU0345776255.USD","SG9999004360.SGD","LU2125910849.SGD","IE0031814969.USD","LU0516422366.SGD","SG9999013460.SGD","LU0532188223.SGD"],"gpt_icon":0},{"id":"2593481843","title":"Onconetix Inc: Files Prospectus for Resale of 29.8 Mln Shares of Common Stock by Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2593481843","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593481843?lang=en_us&edition=fundamental","pubTime":"2025-12-22 19:05","pubTimestamp":1766401559,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XQ02J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2591568216","title":"Onconetix Inc. Files Initial Statement of Beneficial Ownership for Director Sarah Romano","url":"https://stock-news.laohu8.com/highlight/detail?id=2591568216","media":"Reuters","labels":["executive","shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591568216?lang=en_us&edition=fundamental","pubTime":"2025-12-13 07:05","pubTimestamp":1765580729,"startTime":"0","endTime":"0","summary":"Onconetix Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Sarah Romano as the beneficial owner in her role as Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL6FTR06:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Onconetix Inc. Files Initial Statement of Beneficial Ownership for Director Sarah Romano","news_tag":"executive,shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2590559515","title":"Onconetix Inc. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2590559515","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590559515?lang=en_us&edition=fundamental","pubTime":"2025-12-11 06:01","pubTimestamp":1765404087,"startTime":"0","endTime":"0","summary":"Onconetix Inc. held its annual meeting on December 5, 2025. Shareholders approved the issuance of up to 4,424,080 shares of Common Stock upon conversion of Series D Preferred Stock and up to 4,362,827 shares of Common Stock upon the exercise of certain warrants issued in connection with a private placement that closed on September 22, 2025. Approval was also granted for the issuance of up to 2,025,223 shares of Common Stock upon conversion of Series E Preferred Stock and up to 2,025,223 shares of Common Stock upon exercise of certain warrants related to a private placement that closed on October 1, 2025. The appointment of MaloneBailey, LLP as independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified. Shareholders also approved the potential adjournment of the annual meeting to solicit additional proxies if needed.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL4Mhsg3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2590053383","title":"Proteomedix AG Launches PRIME Study Under Onconetix Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2590053383","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590053383?lang=en_us&edition=fundamental","pubTime":"2025-12-10 22:28","pubTimestamp":1765376932,"startTime":"0","endTime":"0","summary":"Proteomedix AG, Subsidiary of Onconetix Inc., Amends License Agreement with Labcorp for Proclarix Validation Study. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL7fStfx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LH","LU0742534661.SGD","BK4585","BK4588","BK4139","LU0251131958.USD","BK4550","LU0251142724.SGD","ONCO","LU1059921491.USD","BK4196","LU0048573561.USD","LU0006061336.USD"],"gpt_icon":0},{"id":"2584925970","title":"Onconetix Inc - Files Prospectus For Resale Of 22.1 Million Shares Of Common Stock By Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584925970","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584925970?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:33","pubTimestamp":1763569994,"startTime":"0","endTime":"0","summary":"Nov 5 (Reuters) - Onconetix Inc ::*ONCONETIX INC - FILES PROSPECTUS FOR RESALE OF 22.1 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 04-NOV-202523:01:04 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD73Rh8T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2581953227","title":"BRIEF-Onconetix Inc - Files Prospectus For Resale Of 22.1 Million Shares Of Common Stock By Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581953227","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581953227?lang=en_us&edition=fundamental","pubTime":"2025-11-05 07:01","pubTimestamp":1762297264,"startTime":"0","endTime":"0","summary":"BRIEF-Onconetix Inc - Files Prospectus For Resale Of 22.1 Million Shares Of Common Stock By Selling Stockholders - SEC FilingNov 5  - Onconetix Inc ONCO.O:ONCONETIX INC - FILES PROSPECTUS FOR RESALE OF 22.1 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILINGSource text: [ID:n0001213900-25-106177]Further company coverage: ONCO.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nFWN3WG17Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2579756489","title":"Onconetix Inc. Announces Date for Upcoming Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2579756489","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579756489?lang=en_us&edition=fundamental","pubTime":"2025-10-29 18:03","pubTimestamp":1761732197,"startTime":"0","endTime":"0","summary":"Onconetix Inc. will hold its Annual Meeting on December 5, 2025. During the meeting, shareholders will be asked to vote on five proposals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nNDL2KqsCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":34,"code":"91000000","status":"200"}]}}